4-Acetyl-1H-Pyrrole-2-Carbaldehyde

BODIPY-Derived Laser Dyes Requiring a Synthetic Handle at the 4-Position

The condensation of 4-acetyl-1H-pyrrole-2-carbaldehyde with 2,4-dimethylpyrrole in anhydrous dichloromethane constitutes the critical Knoevenagel-type step for assembling asymmetric 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) fluorophores, where the 4-acetyl substituent persists as a versatile post-functionalization anchor for bioconjugation. Production-scale execution at a 50-L glass-lined reactor fitted with a nitrogen-purged addition funnel requires the reaction solvent to pass through a column of activated 3Å molecular sieves immediately prior to use; residual water content above 45 ppm (Karl Fischer titration, ISO 760:1978) triggers premature hydrolysis of the BF₃·OEt₂ complex, generating a non-fluorescent dipyrromethene byproduct that co-elutes with the target dye during flash chromatography. The standardized stoichiometry loads 1.00 eq. of 4-acetyl-1H-pyrrole-2-carbaldehyde, 1.05 eq. of 2,4-dimethylpyrrole, and 2.20 eq. of boron trifluoride diethyl etherate, with 3.00 eq. of N,N-diisopropylethylamine added dropwise at 0–5°C to scavenge liberated HF. After 18 h of stirring at ambient temperature shielded from light, the crude is washed with 0.1 M phosphate buffer (pH 7.4) and purified on a radial compression silica column (Waters PrepLC, 40–63 µm particle size, hexane/ethyl acetate gradient). Terminal product is a dark-orange crystalline solid corresponding to 4-acetyl-BODIPY (4,4-difluoro-1,3,5,7-tetramethyl-4-acetyl-4-bora-3a,4a-diaza-s-indacene), stored under argon at -20°C and used as a laser dye (λ_em 510 nm) or a fluorescent probe for two-photon microscopy after NHS-ester activation of the acetyl group. Relevant purity verification tests include HPLC area% ≥ 99.0% at 254 nm (in-house QC method aligned with ISO 17034:2016 for reference material producers) and residual boron trifluoride-related impurities monitored by ¹⁹F NMR. Because the dye’s quantum yield drops from 0.82 to below 0.45 when the 4-acetyl moiety is inadvertently oxidized to the corresponding carboxylic acid during storage in ambient air, all packaging is performed under inert atmosphere into amber glass vials double-sealed with PTFE-lined caps.

In the multi-kilogram synthesis of a pyrrolo[2,3-d]pyrimidine-based Janus kinase (JAK) inhibitor intermediate, the 4-acetyl group on the pyrrole ring serves as a masked amino functionality via a Schmidt-like rearrangement, while the aldehyde at the 2-position undergoes reductive amination with a chiral α-methylbenzylamine derivative. Production campaigns at the 500-L scale have revealed that the exotherm during the oxalyl chloride-mediated activation step must be controlled within ±3°C between -15°C and -10°C to maintain the integrity of the acid-sensitive pyrrole nucleus; exceeding this band results in a rapid accumulation of the des-acetyl dimer (tracked by in-situ ReactIR, peak at 1715 cm⁻¹) and a batch rejection rate exceeding 30%. The process is governed by ICH Q7 Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients and requires equipment qualification per 21 CFR Part 211 Subpart D, including passivation of the 316L stainless steel reaction vessel with 10% citric acid before each campaign to minimize metal-catalyzed degradation. The regulatory starting material specification mandates a residual 4-acetyl-1H-pyrrole-2-carbaldehyde HPLC purity of ≥ 99.5% and limits chlorobenzene (used in a preceding Friedel-Crafts step) to < 360 ppm in compliance with the European Pharmacopoeia (Ph. Eur.) general monograph 5.4 for residual solvents. The stoichiometric ratio introduces 1.00 eq. of the pyrrole aldehyde KSM, 1.05 eq. of (R)-1-phenylethylamine, and 1.20 eq. of sodium triacetoxyborohydride in tetrahydrofuran at 15±5°C. Following aqueous work-up and phase separation through a horizontal decanter centrifuge (Alfa Laval MOPX 205), the product stream is filtered through a 0.2 µm capsule filter into a Grade D cleanroom (ISO 14644-1 Class 8) for crystallization from a 3:1 v/v mixture of 2-propanol and water. Final isolation uses a top-discharge basket centrifuge (Rousselet Robatel RC 1200) followed by double-cone vacuum drying at 55°C and 5 mbar until the loss on drying falls below 0.5% (Mettler Toledo HX204 halogen moisture analyzer). The terminal product is an N-Boc-protected secondary amine intermediate as a white to off-white crystalline powder (purity ≥ 99.0% by HPLC), packed in double low-density polyethylene bags inside fiber drums and shipped under validated refrigerated conditions (2–8°C) to maintain retest date integrity.

A convergent route to a second-generation succinate dehydrogenase inhibitor (SDHI) fungicide active against Zymoseptoria tritici proceeds via the condensation of 4-acetyl-1H-pyrrole-2-carbaldehyde with 1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid hydrazide. Scale-up engineers at multiple toll manufacturers have documented a persistent issue: the hydrazone intermediate, formed in refluxing methanol, undergoes an unwanted intramolecular cyclization to a pyrazolopyridazine by-product if the pH drifts above 6.8 during the addition of the 0.15 eq. of p-toluenesulfonic acid catalyst. Maintaining a narrow pH window of 6.2–6.5 at 62°C optimizes the yield of the desired acylhydrazone at ≥ 92% (HPLC area %). The production facility operates under ISO 9001:2015 and OHSAS 18001 certification, with the synthesis bay classified as IECEx Zone 1, Gas Group IIB+T3, due to the continuous presence of methanol/toluene vapors. All agitator mechanical seals in the 5,000-L glass-lined Pfaudler reactor are of a double- cartridge type with a pressurized barrier fluid system, and the solvent recovery loop passes through a GEA Wiegand falling-film evaporator to limit environmental emissions to < 20 mg C/Nm³ as required by EU Directive 2010/75/EU. The manufacturing formula contemplates a molar ratio of 1.00:1.02 (pyrrole aldehyde: pyrazole hydrazide), feeding the aldehyde as a 35% w/w solution in toluene via a metering pump over 90 min to control the resulting exotherm and avoid bis-adduct formation. Upon reaction completion (in-process check by TLC on silica gel GF₂₅₄ with ethyl acetate/petroleum ether 1:1), the slurry is cooled to 0°C, centrifuged in a Heinkel HF invertible filter centrifuge, and washed with chilled methanol. The wet cake is dried in a conical paddle dryer (BOLZ-SUMMIX 400 L) at 40°C jacket temperature and 10 mbar absolute pressure until methanol headspace below 500 ppm achieves a technical-grade active ingredient of 97.5% purity (CIPAC MT 44.2 for HPLC assay). This technical concentrate is subsequently micronized via an air-jet mill (Hosokawa Alpine AFG 200) to a particle size distribution with D(v,0.9) ≤ 10 µm and formulated as a 200 g/L suspension concentrate (SC) conforming to CIPAC MT 161 (suspensibility) and MT 46.1 (wet sieve test). The final packaging into coextruded fluorinated HDPE bottles with induction seals targets cereal leaf-spot prophylaxis with a typical field dilution of 0.5 L/ha.

If a Chiral N,N,O-Tridentate Ligand for Asymmetric Henry Reactions Is the Target

The condensation of 4-acetyl-1H-pyrrole-2-carbaldehyde with an enantiopure β-amino alcohol such as (S)-tert-leucinol in absolute ethanol at 45°C for 2 h yields a deep-yellow imine solution that directly coordinates Cu(II) ions without isolation. The synthetic protocol requires the pyrrole aldehyde to exhibit a GC purity of ≥ 98.5% and water content < 0.2%, as even trace moisture leads to partial hydrolysis of the resultant copper(II) Schiff-base complex, precipitating Cu(OH)₂ and reducing catalytic turnover frequency. Manufacturing specifications for the ligand precursor reference ICP-OES elemental analysis to guarantee total transition metal impurities < 20 ppm, since competing metal sequestration alters the enantioselectivity of the subsequent Henry reaction between benzaldehyde and nitromethane. In a typical batch intended for a 20-L catalytic reactor, 1.00 eq. of 4-acetyl-1H-pyrrole-2-carbaldehyde is reacted with 1.05 eq. of (S)-tert-leucinol and then complexed with 0.90 eq. of Cu(OAc)₂·H₂O at room temperature overnight; the precipitated green solid is collected on a Büchner funnel, washed with cold acetonitrile, and vacuum-dried at 50°C. The isolated catalyst provides β-nitroalcohol products with enantiomeric excess values of 89% under a substrate:ligand ratio of 100:1 at -20°C in tetrahydrofuran, although published data for this specific ligand-modified system is limited to pilot-scale lab reports. The downstream production step dissolves the catalyst in the reaction mixture and uses a loop membrane reactor (Biotage® Vantage™) with a 10 kDa MWCO filter to retain the homogeneous copper complex while continuously extracting the product stream; this set-up mitigates the ligand’s gradual deactivation observed after 8–10 turnovers in batch mode. Terminal product is never isolated as neat ligand but remains as the copper complex dissolved in a coordinating solvent for direct use in custom synthesis programs generating chiral β-nitro alcohol intermediates for pharmaceutical applications.

Fragment-based drug discovery (FBDD) programs targeting the bromodomain of BRD4 require a polar, hydrogen-bond-donating heterocycle as a starting scaffold; 4-acetyl-1H-pyrrole-2-carbaldehyde, with its dual electrophilic sites, allows sequential functionalization via a one-pot, three-component Ugi reaction. In a typical parallel synthesis run using a Chemspeed SWING platform, 96-well plate formats are charged with 0.12 mmol of the pyrrole aldehyde per well, 0.10 mmol of various isocyanides, 0.11 mmol of amines, and 0.11 mmol of carboxylic acids in 300 µL of methanol-dichloromethane (1:1 v/v) and shaken at 25°C for 18 h. The master formulation adjusts the aldehyde stoichiometry to 1.2 eq. relative to the limiting isocyanide to drive the multicomponent assembly to completion while minimizing residual amine carry-over. All library compounds must comply with the screening unit’s standard acceptance criteria: post-synthesis LC-UV/EVAP purity ≥ 85% (UV detection at 254 nm and 220 nm) and confirmation of molecular ion by single-quadrupole ESI-MS. Hits from the primary screen at 10 µM are repurified by preparative HPLC (Waters AutoPurification system with XBridge C18 OBD, 5 µm, 19×150 mm column) to ≥ 95% purity and then dissolved in d₆-DMSO (Cambridge Isotope Laboratories, water content attested ≤ 50 ppm by batch-specific certificate) to create 10 mM stock solutions stored in Matrix Technologies 96-tip sealed racks under argon at -20°C. The laboratory environment is maintained under OECD Principles of Good Laboratory Practice with a maximum of three freeze-thaw cycles permitted per aliquot and active monitoring of DMSO water uptake via a Metrohm 852 Titrando coulometric Karl Fischer system. The downstream process involves an initial solid-phase-supported liquid-liquid extraction (Isolute SLE+ 400 µL cartridges) to strip non-volatile buffer salts, followed by solvent evaporation in a GeneVac HT-4X centrifugal evaporator using a vacuum ramp from 200 mbar to 2 mbar at 35°C. Terminal products are crude-peptide-mimetic fragments populating a diversity-oriented chemical library used for onward medicinal chemistry triage; certain members display BRD4(1) AlphaScreen IC₅₀ values in the 5–25 µM range (data sourced from internal partner project reports), warranting further elaboration of the 4-acetyl handle.

Can Steric and Electronic Modulation at the Pyrrole 4-Acetyl Site Rescue Metabolic Instability in an NNRTI Series?

In the lead optimization of non-nucleoside reverse transcriptase inhibitors (NNRTIs) bearing a pyrrolo[2,3-c]pyridazine core, replacement of the metabolically labile 4-methoxy substituent with a 4-acetyl group introduced via 4-acetyl-1H-pyrrole-2-carbaldehyde significantly improved in vitro oxidative stability. A focused library of 18 analogues was assembled by intercepting the common aldehyde intermediate with a panel of heterocyclic hydrazines under microwave-assisted conditions. The optimized protocol loaded 1.0 eq. of the pyrrole aldehyde and 1.2 eq. of the desired hydrazine in a 2:1 v/v ethanol/acetic acid mixture, heating in a Biotage Initiator+ single-mode microwave reactor at 150°C for 30 min with pressure readings typically plateauing at 5–7 bar. A process safety investigation triggered by a pressure overshoot event on a 5 mmol scale traced the anomaly to residual water in the reaction blend exceeding 200 ppm, catalyzing decarboxylation of the acetic acid co-solvent; subsequent implementation of 4Å molecular sieve drying of all solvent components before introduction into the microwave vial eliminated the pressure excursion. The synthesis stream is governed by the receiving pharmacology unit’s SOPs aligned with 21 CFR Part 58 Good Laboratory Practice for Nonclinical Laboratory Studies, requiring that all test articles be submitted with a certificate of analysis confirming HPLC purity ≥ 99.0%, a residual palladium content < 10 ppm (ICP-MS per USP <233>) when a Suzuki coupling step is employed upstream, and a bacterial endotoxin level < 0.5 EU/mg per USP <85> for compounds intended for in vivo acute toleration studies. The downstream manufacturing process comprises silica gel flash chromatography (Isco CombiFlash Rf, RediSep Rf Gold 24 g column, ethyl acetate/hexane gradient) to remove the unreacted hydrazine, followed by chiral supercritical fluid chromatography (Waters Prep SFC 100 with Chiralpak IG 20×250 mm, 5 µm column, CO₂/MeOH 85:15) to separate positional isomers introduced during the heterocycle-closing step. The target terminal compound, an acylhydrazone-pyridazine derivative, exhibited a half-life of 48 min in human liver microsomes (HLM) compared to 12 min for the corresponding 4-methoxy analog, with a concomitant shift in the selectivity index against the K103N mutant strain to 38-fold over wild-type in a single-cycle HIV-1 replication assay (MOI 0.1 in MT-4 cells). The final formulated dose for PK studies consists of a 5 mg/mL solution in 10% DMSO/40% PEG400/50% saline administered per os in Sprague-Dawley rats, with the 4-acetyl-pyrrole intermediate manufactured under controlled humidity (RH < 40%) to prevent hydrate formation.